ArticleCPT: pharmacometrics & systems pharmacology2021

Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose.

Wenyuan Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.